Compliance With Recommendations of the Surveillance, Epidemiology, and End Results (SEER) Treatment Data Use Agreement: A Review of Published Studies
The Surveillance, Epidemiology, and End Results (SEER) Program collects data on the first course of cancer treatment, but no and unknown receipt of treatment cannot be distinguished for radiation therapy (RT) and chemotherapy. As part of the Data Use Agreement (DUA), users must acknowledge that they...
Uloženo v:
| Vydáno v: | Medical care Ročník 63; číslo 12; s. 899 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.12.2025
|
| Témata: | |
| ISSN: | 1537-1948, 1537-1948 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The Surveillance, Epidemiology, and End Results (SEER) Program collects data on the first course of cancer treatment, but no and unknown receipt of treatment cannot be distinguished for radiation therapy (RT) and chemotherapy. As part of the Data Use Agreement (DUA), users must acknowledge that they understand the data limitations and agree to include a description of the limitations in any analyses published using the data. The objective of this review was to evaluate users' compliance with the recommendations of the DUA.
Publications from a PubMed search were matched with the names of SEER treatment data users, and keywords were applied to identify relevant studies. Five reviewers (with 2 per publication) independently assessed if the authors (a) conducted analyses supported by these data, (b) correctly labelled no/unknown treatment as "no/unknown", and (c) described the limitations of their use. Publications were classified as "followed recommendations", "partially followed recommendations", or "did not follow recommendations" of the DUA.
Among a total of 120 studies included in the review, 106 (88.3%) studies did not follow recommendations, 11 (9.2%) partially followed recommendations, and 3 studies (2.5%) followed recommendations. Only 11.7% of publications correctly labelled the "no/unknown" category as "no/unknown", and described the limitations associated with the no/unknown issue.
In this review, we found substantial misuse of the SEER treatment data and limited acknowledgement of the limitations of the SEER treatment data in publications. Such findings highlight the need to think of effective ways of encouraging appropriate use of the treatment data. |
|---|---|
| AbstractList | The Surveillance, Epidemiology, and End Results (SEER) Program collects data on the first course of cancer treatment, but no and unknown receipt of treatment cannot be distinguished for radiation therapy (RT) and chemotherapy. As part of the Data Use Agreement (DUA), users must acknowledge that they understand the data limitations and agree to include a description of the limitations in any analyses published using the data. The objective of this review was to evaluate users' compliance with the recommendations of the DUA.
Publications from a PubMed search were matched with the names of SEER treatment data users, and keywords were applied to identify relevant studies. Five reviewers (with 2 per publication) independently assessed if the authors (a) conducted analyses supported by these data, (b) correctly labelled no/unknown treatment as "no/unknown", and (c) described the limitations of their use. Publications were classified as "followed recommendations", "partially followed recommendations", or "did not follow recommendations" of the DUA.
Among a total of 120 studies included in the review, 106 (88.3%) studies did not follow recommendations, 11 (9.2%) partially followed recommendations, and 3 studies (2.5%) followed recommendations. Only 11.7% of publications correctly labelled the "no/unknown" category as "no/unknown", and described the limitations associated with the no/unknown issue.
In this review, we found substantial misuse of the SEER treatment data and limited acknowledgement of the limitations of the SEER treatment data in publications. Such findings highlight the need to think of effective ways of encouraging appropriate use of the treatment data. The Surveillance, Epidemiology, and End Results (SEER) Program collects data on the first course of cancer treatment, but no and unknown receipt of treatment cannot be distinguished for radiation therapy (RT) and chemotherapy. As part of the Data Use Agreement (DUA), users must acknowledge that they understand the data limitations and agree to include a description of the limitations in any analyses published using the data. The objective of this review was to evaluate users' compliance with the recommendations of the DUA.INTRODUCTIONThe Surveillance, Epidemiology, and End Results (SEER) Program collects data on the first course of cancer treatment, but no and unknown receipt of treatment cannot be distinguished for radiation therapy (RT) and chemotherapy. As part of the Data Use Agreement (DUA), users must acknowledge that they understand the data limitations and agree to include a description of the limitations in any analyses published using the data. The objective of this review was to evaluate users' compliance with the recommendations of the DUA.Publications from a PubMed search were matched with the names of SEER treatment data users, and keywords were applied to identify relevant studies. Five reviewers (with 2 per publication) independently assessed if the authors (a) conducted analyses supported by these data, (b) correctly labelled no/unknown treatment as "no/unknown", and (c) described the limitations of their use. Publications were classified as "followed recommendations", "partially followed recommendations", or "did not follow recommendations" of the DUA.METHODSPublications from a PubMed search were matched with the names of SEER treatment data users, and keywords were applied to identify relevant studies. Five reviewers (with 2 per publication) independently assessed if the authors (a) conducted analyses supported by these data, (b) correctly labelled no/unknown treatment as "no/unknown", and (c) described the limitations of their use. Publications were classified as "followed recommendations", "partially followed recommendations", or "did not follow recommendations" of the DUA.Among a total of 120 studies included in the review, 106 (88.3%) studies did not follow recommendations, 11 (9.2%) partially followed recommendations, and 3 studies (2.5%) followed recommendations. Only 11.7% of publications correctly labelled the "no/unknown" category as "no/unknown", and described the limitations associated with the no/unknown issue.RESULTSAmong a total of 120 studies included in the review, 106 (88.3%) studies did not follow recommendations, 11 (9.2%) partially followed recommendations, and 3 studies (2.5%) followed recommendations. Only 11.7% of publications correctly labelled the "no/unknown" category as "no/unknown", and described the limitations associated with the no/unknown issue.In this review, we found substantial misuse of the SEER treatment data and limited acknowledgement of the limitations of the SEER treatment data in publications. Such findings highlight the need to think of effective ways of encouraging appropriate use of the treatment data.CONCLUSIONSIn this review, we found substantial misuse of the SEER treatment data and limited acknowledgement of the limitations of the SEER treatment data in publications. Such findings highlight the need to think of effective ways of encouraging appropriate use of the treatment data. |
| Author | Howlader, Nadia Lewis, Denise R Hong, Yoon Duk Noone, Anne-Michelle Feuer, Eric J Scoppa, Steve Mariotto, Angela B |
| Author_xml | – sequence: 1 givenname: Yoon Duk surname: Hong fullname: Hong, Yoon Duk organization: Kelly Services, Inc., Rockville, MD – sequence: 2 givenname: Angela B surname: Mariotto fullname: Mariotto, Angela B organization: Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD – sequence: 3 givenname: Denise R surname: Lewis fullname: Lewis, Denise R organization: Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD – sequence: 4 givenname: Anne-Michelle surname: Noone fullname: Noone, Anne-Michelle organization: Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD – sequence: 5 givenname: Nadia surname: Howlader fullname: Howlader, Nadia organization: Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD – sequence: 6 givenname: Steve surname: Scoppa fullname: Scoppa, Steve organization: Information Management Services, Calverton, MD – sequence: 7 givenname: Eric J surname: Feuer fullname: Feuer, Eric J organization: Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40982777$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkG9LwzAQxoNMnJt-A5G8nLDOJF3Xxndj1j8wUbqJL0faXLZI28wmneyD-H1tccIO7p7j-PEcdz3UKU0JCF1RMqKEh7cv82REjoIxGp2gcxr4oUf5OOoc9V3Us_aTEBr6ATtD3THhEQvD8Bz9zEyxzbUoM8Af2m1wApkpCiilcNqUFhuF3Qbwoq52oPO8BYc43moJhTa5We-HWJQSx00mYOvcWTxYxHFyg5cVCNc4OXwvnMDvFvB0XQG0ozs8bfCdhu92wVud5tpuQOKFq6UGe4FOlcgtXB60j5YP8XL25M1fH59n07mXMcYijzclTSFVQvEsS-UkVYHghNIgIlIJUIpCxseh4oIKEghBJQkFURmXUUoJ66PBn-22Ml81WLcqtM2gvRJMbVc-C_wxZT6bNOj1Aa3TAuRqW-lCVPvV_yfZL-J7eiA |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/MLR.0000000000002218 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1537-1948 |
| ExternalDocumentID | 40982777 |
| Genre | Journal Article Review |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | --- -~X .-D ..I .Z2 01R 0R~ 1J1 3R3 40H 4Q1 4Q2 4Q3 5GY 5VS 71W 77Y 7O~ 8L- AAAAV AAAXR AAGIX AAHPQ AAIQE AAMOA AAMTA AAQKA AARTV AASCR AASOK AAWTL AAWTO AAXQO AAYEP ABASU ABBUW ABDIG ABIVO ABJNI ABPPZ ABPXF ABVCZ ABXVJ ABZAD ABZZY ACBKD ACDDN ACEWG ACGFO ACGFS ACHQT ACILI ACLDA ACLED ACNWC ACWDW ACWRI ACXJB ACXNZ ACZKN ADGGA ADHPY ADKSD ADSXY AE6 AELLO AENEX AFBFQ AFDTB AFRAH AFUWQ AGINI AHMBA AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJRGT AJZMW AKBRZ AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BOYCO BQLVK C45 CGR CS3 CUY CVF DIWNM DU5 E.X EBS ECM EEVPB EIF ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL H0~ HLJTE HZ~ H~9 IH2 IKREB IKYAY IN~ IPNFZ JAA JF9 JG8 JK3 JK8 KD2 KMI L-C L7B N9A NPM N~7 N~B O9- OAG OAH ODZKP OL1 OLG OLH OLL OLU OLV OLY OLZ OPUJH OPX OVD OVDNE OVIDH OVLEI OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RIG RLZ S4R S4S TEORI TN5 TSPGW V2I VVN W3M WH7 WOQ WOW X3V X3W XFW XXN XYM YFH YOC ZFV ZY1 7X8 |
| ID | FETCH-LOGICAL-c2228-9228bbebfaf9ccbd6bf5a9011580dfaeff1ec947f9a1a05aa1d07a0fc9d8b102 |
| IEDL.DBID | 7X8 |
| ISSN | 1537-1948 |
| IngestDate | Tue Sep 23 22:53:11 EDT 2025 Fri Nov 14 01:41:00 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | SEER treatment data data use agreement cancer treatment |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2228-9228bbebfaf9ccbd6bf5a9011580dfaeff1ec947f9a1a05aa1d07a0fc9d8b102 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&DO=10.1097/MLR.0000000000002218 |
| PMID | 40982777 |
| PQID | 3253412326 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3253412326 pubmed_primary_40982777 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-December |
| PublicationDateYYYYMMDD | 2025-12-01 |
| PublicationDate_xml | – month: 12 year: 2025 text: 2025-December |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Medical care |
| PublicationTitleAlternate | Med Care |
| PublicationYear | 2025 |
| SSID | ssj0017352 |
| Score | 2.4855177 |
| SecondaryResourceType | review_article |
| Snippet | The Surveillance, Epidemiology, and End Results (SEER) Program collects data on the first course of cancer treatment, but no and unknown receipt of treatment... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 899 |
| SubjectTerms | Guideline Adherence - statistics & numerical data Humans Neoplasms - therapy SEER Program - standards SEER Program - statistics & numerical data United States |
| Title | Compliance With Recommendations of the Surveillance, Epidemiology, and End Results (SEER) Treatment Data Use Agreement: A Review of Published Studies |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40982777 https://www.proquest.com/docview/3253412326 |
| Volume | 63 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fS9xAEF5alSKIrbb-bMsIPrTgYpJLbje-yGEjffAOOa_03o7ZX1TQnJo7wT_E_9fZZMM9FQQXsk8JCdnZ2W9mvt2PsUM0qUsNxhzJ_XNCxJIrITs8Ri9XKAy1WrXkQgwGcjzOL0PCrQq0ytYn1o7aTLXPkR93kowcLq3_3dO7e-5Vo3x1NUhovGfLHYIy3qrFeFFFEJ1acYcmteAUrMt261wujvsXw-bowtCSJJb_B5n1YnP-8a2f-YmtB5gJvcYuNtg7W26yD_1QSN9ka026DppdSJ_Z81lNLfcmAH-vZ__Ah6W3tzZILlUwdUBQEa7mD4_WCxXRjUdQLORln44ASwMFXUNbzW9mFfy4KorhTxi1VHb4hTOEP5WFHgX5dVryBHrQVCf8C1qKvoHAbvzCRufF6Ow3D4oNXPtMEs-pU8oqhy7XWpmuchn6za2ZjIxD61xsdZ4Kl2OMUYYYm0hg5HRupCKos8WWymlpdxhg7JzudlWqtE4Rc9SZROEI34kYhY522UH7_yc0IXyVA0s7nVeTxQjssu1mECd3zckdEwpmZSKE2HvF0_tsNfFavzV15StbduQO7De2oh9n19XD99rSqB9c9l8A6c3evw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Compliance+With+Recommendations+of+the+Surveillance%2C+Epidemiology%2C+and+End+Results+%28SEER%29+Treatment+Data+Use+Agreement%3A+A+Review+of+Published+Studies&rft.jtitle=Medical+care&rft.au=Hong%2C+Yoon+Duk&rft.au=Mariotto%2C+Angela+B&rft.au=Lewis%2C+Denise+R&rft.au=Noone%2C+Anne-Michelle&rft.date=2025-12-01&rft.eissn=1537-1948&rft.volume=63&rft.issue=12&rft.spage=899&rft_id=info:doi/10.1097%2FMLR.0000000000002218&rft_id=info%3Apmid%2F40982777&rft_id=info%3Apmid%2F40982777&rft.externalDocID=40982777 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-1948&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-1948&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-1948&client=summon |